CT-SEGMENTED BONE SUV IN MULTIPLE MYELOMA: A COMPARATIVE STUDY OF ¹⁸F-FDG AND ⁶⁸GA-PSMA PET/CT

¹⁸F-FDG PET/CT is widely used in the management of multiple myeloma (MM), a disease that often presents with extensive bone involvement. Radiolabeled prostate-specific membrane antigen (PSMA), primarily a marker for prostate cancer, is also associated with tumor neoangiogenesis, and studies have demonstrated its uptake in MM lesions. Hybrid PET/CT imaging with both FDG and PSMA tracers allows for several quantitative metrics, enabling objective comparisons beyond visual analysis. This study aims to compare ¹⁸F-FDG and ⁶⁸Ga-PSMA PET/CT quantitative metrics in the skeletal system of patients with MM. The study included ¹⁸F-FDG and ⁶⁸Ga-PSMA PET/CT images acquired within a 1- to 8-day interval from 15 patients (53% male, mean age 66.7 ± 10.7 years) with symptomatic, biopsy-proven MM. CT was used to segment the entire skeleton in PET images, with the skull excluded in ¹⁸F-FDG images due to artifacts from brain uptake coregistration. SUV quantification was performed using in-house software developed in MATLAB. Descriptive statistics and individual percentage deviations between the radiotracers were used to evaluate bone mean and maximum Standardized Uptake Values (SUVmean and SUVmax). Correlation analysis between the radiotracers was conducted using Spearman's rank correlation coefficient (r) with a significance level of p < 0.05. For bone SUVmean, values were higher for ¹⁸F-FDG compared to ⁶⁸Ga-PSMA, with an average of 0.9 ± 0.1 vs. 0.5 ± 0.1, corresponding to a -40% ± 9% difference (range: -25% to -57%). Conversely, for bone SUVmax, values were lower for ¹⁸F-FDG compared to ⁶⁸Ga-PSMA, with an average of 8 ± 3 vs. 19 ± 14, corresponding to a 154% ± 2% difference (range: -21% to 762%). A moderate correlation was found for bone SUVmean between ¹⁸F-FDG and ⁶⁸Ga-PSMA (r = 0.55, p = 0.03), while no significant correlation was observed for bone SUVmax (r = 0.17, p = 0.55). This study reveals distinct quantitative uptake patterns between ¹⁸F-FDG and ⁶⁸Ga-PSMA PET/CT in the skeletal system of MM patients. ¹⁸F-FDG exhibited significantly higher SUVmean than ⁶⁸Ga-PSMA, likely due to physiological ¹⁸F-FDG uptake in bone marrow. A moderate correlation was observed for SUVmean between the two tracers. The higher SUVmax values for ⁶⁸Ga-PSMA, with no correlation with ¹⁸F-FDG SUVmax, may reflect the different biological targeting mechanisms of each tracer. This suggests that some regions of increased PSMA uptake (possibly indicating neoangiogenesis) may not correspond to areas of increased glycolysis, highlighting the potential complementary role of these radiotracers in MM evaluation.

Authors

Institutions

Publication Details

Journal
Hematology Transfusion and Cell Therapy
Published
2025-04-15
DOI
https://doi.org/10.1016/j.htct.2025.103803
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CT-SEGMENTED BONE SUV IN MULTIPLE MYELOMA: A COMPARATIVE STUDY OF ¹⁸F-FDG AND ⁶⁸GA-PSMA PET/CT

SUZI RIANE SILVA DE SOUZA, Celso Darío Ramos, Maria Emília Seren Takahashi, Irene Lorand‐Metze et al.
Hematology Transfusion and Cell Therapy
Multiple Myeloma Research and Treatments
article

CT-SEGMENTED BONE SUV IN MULTIPLE MYELOMA: A COMPARATIVE STUDY OF ¹⁸F-FDG AND ⁶⁸GA-PSMA PET/CT

SUZI RIANE SILVA DE SOUZA, Celso Darío Ramos, Maria Emília Seren Takahashi, Irene Lorand‐Metze, Cármino Antônio De Souza, Ana Barbosa, Edna Marina de Souza, Sérgio Querino Brunetto
article en

Abstract

¹⁸F-FDG PET/CT is widely used in the management of multiple myeloma (MM), a disease that often presents with extensive bone involvement. Radiolabeled prostate-specific membrane antigen (PSMA), primarily a marker for prostate cancer, is also associated with tumor neoangiogenesis, and studies have demonstrated its uptake in MM lesions. Hybrid PET/CT imaging with both FDG and PSMA tracers allows for several quantitative metrics, enabling objective comparisons beyond visual analysis. This study aims to compare ¹⁸F-FDG and ⁶⁸Ga-PSMA PET/CT quantitative metrics in the skeletal system of patients with MM. The study included ¹⁸F-FDG and ⁶⁸Ga-PSMA PET/CT images acquired within a 1- to 8-day interval from 15 patients (53% male, mean age 66.7 ± 10.7 years) with symptomatic, biopsy-proven MM. CT was used to segment the entire skeleton in PET images, with the skull excluded in ¹⁸F-FDG images due to artifacts from brain uptake coregistration. SUV quantification was performed using in-house software developed in MATLAB. Descriptive statistics and individual percentage deviations between the radiotracers were used to evaluate bone mean and maximum Standardized Uptake Values (SUVmean and SUVmax). Correlation analysis between the radiotracers was conducted using Spearman's rank correlation coefficient (r) with a significance level of p < 0.05. For bone SUVmean, values were higher for ¹⁸F-FDG compared to ⁶⁸Ga-PSMA, with an average of 0.9 ± 0.1 vs. 0.5 ± 0.1, corresponding to a -40% ± 9% difference (range: -25% to -57%). Conversely, for bone SUVmax, values were lower for ¹⁸F-FDG compared to ⁶⁸Ga-PSMA, with an average of 8 ± 3 vs. 19 ± 14, corresponding to a 154% ± 2% difference (range: -21% to 762%). A moderate correlation was found for bone SUVmean between ¹⁸F-FDG and ⁶⁸Ga-PSMA (r = 0.55, p = 0.03), while no significant correlation was observed for bone SUVmax (r = 0.17, p = 0.55). This study reveals distinct quantitative uptake patterns between ¹⁸F-FDG and ⁶⁸Ga-PSMA PET/CT in the skeletal system of MM patients. ¹⁸F-FDG exhibited significantly higher SUVmean than ⁶⁸Ga-PSMA, likely due to physiological ¹⁸F-FDG uptake in bone marrow. A moderate correlation was observed for SUVmean between the two tracers. The higher SUVmax values for ⁶⁸Ga-PSMA, with no correlation with ¹⁸F-FDG SUVmax, may reflect the different biological targeting mechanisms of each tracer. This suggests that some regions of increased PSMA uptake (possibly indicating neoangiogenesis) may not correspond to areas of increased glycolysis, highlighting the potential complementary role of these radiotracers in MM evaluation.

Hematology Transfusion and Cell TherapyVol. 47
Universidade Estadual de Campinas (UNICAMP) (BR)
Zero hunger
Openalex Percentile: Top 90%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.